SCHEMBL30769520

SCHEMBL30769520

O=CN1CCC(c2ccnc3[nH]c(C4CCOCC4)nc23)CC1

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ ATR Q13535 3/20 0.34
▸ ATRIP Q8WXE1 2/20 0.34
▸ PDE10A Q9Y233 3/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ CCNT1 O60563 1/20 0.32
▸ CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27059765 0.97 IRAK4 (0.34) IRAK4ATRATRIPPDE10AHTR2B
SCHEMBL30769742 0.97 IRAK4 (0.34) IRAK4ATRATRIPPDE10AHTR2B
SCHEMBL30769800 0.94 IRAK4 (0.33) IRAK4ATRATRIPPDE10A
SCHEMBL30769968 0.94 PDE10A (0.36) IRAK4ATRATRIPPDE10AHTR2B
SCHEMBL30769965 0.88 PARP1 (0.37) CDK9
SCHEMBL32664786 0.87 ATR (0.36) ATR
SCHEMBL27059126 0.85 CCNT1 (0.43) IRAK4ATRATRIPHTR2BCCNT1
SCHEMBL30769756 0.84 PARP1 (0.31) HTR2B
SCHEMBL30769850 0.84 PARP1 (0.41) HTR2B
SCHEMBL30769822 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4558500-A1 IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF Sanofi (FR) 2025-05-28 — — EP claimed
WO-2024017977-A1 IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI (FR) 2024-01-25 — — WO claimed
EP-4558500-A1 IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF Sanofi (FR) 2025-05-28 — — EP disclosed
WO-2024017977-A1 IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF SANOFI (FR) 2024-01-25 — — WO disclosed
Send feedback